Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Glory View Technology
301396
4
Guangzhou Sie Consulting
300687
5
Tibet Duo Rui Pharmaceutical
301075
CN Stock MarketDetailed Quotes
002030 Daan Gene Co.,Ltd.
- 5.87
- -0.19-3.14%
Not Open Mar 31 15:00 CST
8.24BMarket Cap-8.91P/E (TTM)
6.03High5.80Low178.06KlotVolume6.01Open6.06Pre Close104.78MTurnover1.27%Turnover RatioLossP/E (Static)1.40BShares7.8452wk High1.05P/B8.24BFloat Cap4.7152wk Low6.67Limit Up1.40BShs Float29.99Historical High5.45Limit Down3.80%Amplitude-2.92Historical Low0.02Dividend TTM5.88Avg Price99.72KlotAsk0.26%Div YieldTTM100Lot Size76.07KlotBid
Daan Gene Co.,Ltd. Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -55.55%1.44B | -61.09%1.01B | -64.46%665.35M | -69.06%309.28M | -68.62%3.24B | -65.45%2.59B | -61.40%1.87B | -60.85%999.69M | 45.56%10.32B | 52.18%7.51B |
| Refunds of taxes and levies | -99.48%580.13K | -99.82%151.19K | -99.83%144.23K | -95.20%112.93K | 1,056.19%111.32M | 987.62%86.16M | 1,389.12%85.94M | -37.67%2.35M | -15.93%9.63M | -13.64%7.92M |
| Net deposit increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in borrowings from central bank | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in placements from other financial institutions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash received from interests, fees and commissions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in repurchase business capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Premiums received from original insurance contracts | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net cash received from reinsurance business | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in deposits from policyholders | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net increase in funds disbursed | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net cash received from trading securities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash received relating to other operating activities | -2.62%976.79M | -22.71%639.45M | -12.38%464.03M | -13.21%208.26M | 24.52%1B | 30.34%827.3M | 31.74%529.57M | -42.13%239.95M | -12.13%805.54M | -11.72%634.73M |
| Cash inflows from operating activities | -44.48%2.42B | -52.99%1.65B | -54.59%1.13B | -58.32%517.65M | -60.91%4.35B | -56.96%3.51B | -52.69%2.49B | -58.21%1.24B | 38.88%11.14B | 43.96%8.15B |
| Goods services cash paid | -49.56%536.94M | -62.20%371.21M | -64.07%249.82M | -70.49%128.04M | -64.98%1.06B | -56.17%982.13M | -53.02%695.38M | -54.89%433.86M | 39.51%3.04B | 34.89%2.24B |
| Staff behalf paid | -52.91%468.27M | -52.74%443.4M | -57.32%353.79M | -63.24%251.85M | -8.98%994.5M | 10.06%938.14M | 50.26%829M | 72.74%685.17M | 56.47%1.09B | 62.39%852.39M |
| All taxes paid | -85.94%51.34M | -91.74%30.61M | -93.29%23.83M | -91.46%14.27M | -75.88%365.08M | -68.12%370.56M | -56.60%355.44M | 19.67%167M | 97.66%1.51B | 80.35%1.16B |
| Net loan and advance increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net deposit in central bank and institutions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net lend capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid for fees and commissions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid for indemnity of original insurance contract | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Policy dividend cash paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid relating to other operating activities | -7.74%1.06B | -28.01%671.34M | -25.38%482.14M | -32.63%213.29M | -14.02%1.15B | -8.29%932.6M | -7.50%646.14M | -50.10%316.6M | 24.69%1.34B | 54.68%1.02B |
| Cash outflows from operating activities | -40.76%2.12B | -52.95%1.52B | -56.07%1.11B | -62.10%607.45M | -48.82%3.57B | -38.86%3.22B | -28.84%2.53B | -24.85%1.6B | 48.09%6.98B | 51.16%5.27B |
| Net cash flows from operating activities | -61.50%300.33M | -53.41%132.42M | 151.98%19.95M | 75.10%-89.8M | -81.22%780.11M | -90.12%284.23M | -102.25%-38.38M | -142.96%-360.63M | 25.73%4.15B | 32.41%2.88B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -73.05%399.64M | -82.62%231.57M | -88.40%151.57M | -59.11%137.56M | -1.64%1.48B | 56.48%1.33B | 89.61%1.31B | -19.93%336.39M | -31.30%1.51B | -51.31%851.74M |
| Cash received from returns on investments | -56.03%28.86M | -63.38%20.58M | 178.48%20.17M | -69.24%341.54K | 34.62%65.65M | 85.48%56.18M | -45.55%7.24M | -71.34%1.11M | 85.25%48.77M | 131.33%30.29M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -76.35%106.18K | 954.24%86.5K | 15,900.00%32K | 15,900.00%32K | 3,548.03%448.93K | -94.82%8.21K | --200 | --200 | -92.04%12.31K | 26.85%158.45K |
| Net cash received from disposal of subsidiaries and other business units | --23.58 | 313.20%23.58 | --0 | --0 | --0 | -100.00%-11.06 | --0 | ---- | --0 | 358,956.26%161.35M |
| Cash received relating to other investing activities | 44.70%1.14B | -45.28%430M | -74.55%200M | --0 | -30.99%789.95M | 54.64%785.76M | 161.92%785.76M | 202.32%302.32M | --1.14B | --508.13M |
| Cash inflows from investing activities | -32.80%1.57B | -68.63%682.24M | -82.29%371.78M | -78.44%137.93M | -13.41%2.34B | 40.15%2.17B | 80.42%2.1B | 22.11%639.82M | 21.61%2.7B | -11.96%1.55B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -69.55%174.41M | -69.53%94.08M | -70.98%77.92M | -60.30%71.9M | -61.88%572.77M | -69.78%308.73M | -51.87%268.55M | 42.68%181.12M | 128.10%1.5B | 285.08%1.02B |
| Cash paid to acquire investments | -65.95%371.2M | -68.80%301.19M | -75.99%210.12M | -74.61%67.81M | -23.84%1.09B | 43.73%965.33M | 126.68%875.08M | -11.27%267.08M | -14.37%1.43B | -43.10%671.63M |
| Net cash paid to acquire subsidiaries and other business units | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Impawned loan net increase | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash paid relating to other investing activities | 68.09%1.24B | -7.39%450M | -69.54%120M | -66.77%100M | -57.16%739.75M | -57.15%485.89M | -33.46%393.91M | -49.17%300.92M | 35.98%1.73B | --1.13B |
| Cash outflows from investing activities | -25.54%1.79B | -51.97%845.27M | -73.46%408.04M | -68.00%239.71M | -48.45%2.4B | -37.75%1.76B | 0.10%1.54B | -26.55%749.12M | 29.46%4.66B | 95.57%2.83B |
| Net cash flows from investing activities | -241.33%-217.39M | -139.31%-163.03M | -106.45%-36.26M | 6.89%-101.78M | 96.75%-63.69M | 132.52%414.76M | 251.05%562.23M | 77.96%-109.31M | -42.09%-1.96B | -502.45%-1.28B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -95.31%750K | -92.50%750K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -95.31%750K | --0 |
| Cash from borrowing | -53.58%147.85M | -66.43%91.58M | -82.53%45M | 75.37%27.57M | 155.63%318.52M | 380.70%272.82M | 1,206.58%257.55M | 47.59%15.72M | -56.21%124.6M | -79.00%56.75M |
| Cash received relating to other financing activities | 33.71%46.8M | 133.41%46.8M | 99.00%39.8M | --10M | -30.05%35M | -66.58%20.05M | -58.33%20M | --0 | 11.19%50.03M | 39.47%60M |
| Cash inflows from financing activities | -44.94%194.65M | -52.75%138.38M | -69.45%84.8M | 138.99%37.57M | 101.57%353.52M | 149.24%292.87M | 309.90%277.55M | -48.72%15.72M | -49.24%175.39M | -63.65%117.5M |
| Borrowing repayment | 185.09%357.67M | 160.39%301.63M | 294.64%282.62M | -14.23%41.73M | -55.88%125.46M | -63.34%115.84M | -5.61%71.61M | -2.34%48.66M | -28.69%284.34M | -16.16%315.98M |
| Dividend interest payment | -98.87%27.88M | -98.89%27.32M | -98.93%26.4M | 107.96%2.32M | 56.11%2.47B | 56.68%2.47B | 55.97%2.47B | -65.85%1.11M | 203.37%1.58B | 212.32%1.58B |
| -Including:Cash payments for dividends or profit to minority shareholders | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -53.07%11.71M | --0 |
| Cash payments relating to other financing activities | -81.79%15.06M | -24.37%1.46M | -39.41%687.47K | 111.92%1.21M | -20.73%82.7M | -86.98%1.93M | -86.20%1.13M | -85.90%572.7K | 100.32%104.33M | -72.73%14.8M |
| Cash outflows from financing activities | -85.03%400.61M | -87.23%330.41M | -87.81%309.71M | -10.10%45.26M | 35.88%2.68B | 35.69%2.59B | 52.47%2.54B | -11.90%50.34M | 102.66%1.97B | 103.79%1.91B |
| Net cash flows from financing activities | 91.14%-205.96M | 91.63%-192.03M | 90.06%-224.91M | 77.78%-7.69M | -29.46%-2.32B | -28.23%-2.3B | -41.57%-2.26B | -30.68%-34.62M | -186.43%-1.79B | -192.11%-1.79B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -50.71%1.11M | -105.36%-341.71K | -96.81%372.76K | 101.49%55.97K | -91.80%2.26M | -81.38%6.37M | 4,209.49%11.68M | -331.65%-3.75M | 949.25%27.53M | 12,341.47%34.24M |
| Net increase in cash and cash equivalents | 92.40%-121.9M | 85.98%-222.99M | 86.06%-240.85M | 60.81%-199.21M | -474.96%-1.6B | -939.27%-1.59B | -557.49%-1.73B | -260.83%-508.31M | -66.97%427.93M | -108.15%-152.98M |
| Add:Begin period cash and cash equivalents | -61.86%989.27M | -61.86%989.27M | -61.86%989.27M | -61.86%989.27M | 19.76%2.59B | 19.76%2.59B | 19.76%2.59B | 19.76%2.59B | 148.83%2.17B | 148.83%2.17B |
| End period cash equivalent | -12.32%867.37M | -23.67%766.29M | -13.60%748.42M | -62.12%790.06M | -61.86%989.27M | -50.13%1B | -54.49%866.21M | -15.97%2.09B | 19.76%2.59B | -26.75%2.01B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.